Structure | Chemical Name | CAS | MF |
|
1,4-DICYANO-2,3-DIMETHYLBENZENE
|
103754-49-0
|
C10H8N2
|
|
3-Methyl-5-nitroquinoline
|
103754-53-6
|
C10H8N2O2
|
|
5-Benzothiazoleacetonitrile,2-methyl-(6CI,9CI)
|
103754-68-3
|
C10H8N2S
|
|
3-(4-THIOPHEN-2-YL-THIAZOL-2-YLAMINO)-BENZOIC ACID
|
103755-01-7
|
C14H10N2O2S2
|
|
2-(1H-INDAZOL-3-YL)-ACETAMIDE
|
103755-46-0
|
C9H9N3O
|
|
Quinoxaline, 7-amino-5-methoxy- (6CI)
|
103755-50-6
|
C9H9N3O
|
|
6-hydrazinylquinoline hydrochloride
|
103755-52-8
|
C9H10ClN3
|
|
Formamide, N-[1-methyl-7-benzimidazolyl]- (6CI)
|
103755-54-0
|
C9H9N3O
|
|
5-aMino-1-phenyl-1H-pyrazol-3-ol
|
103755-56-2
|
C9H9N3O
|
|
CHEMBRDG-BB 4011498
|
103755-57-3
|
C9H9N3O
|
|
(1-Phenyl-1H-1,2,3-triazol-4-yl)methanol
|
103755-58-4
|
C9H9N3O
|
|
7-Oxa-2,5-diazabicyclo[2.2.1]heptane,2,3,3,5,6,6-hexamethyl-(6CI)
|
103755-80-2
|
C10H20N2O
|
|
Fatty acids, C18-unsatd., dimers, polymers with tall-oil fatty acids and tetraethylenepentamine
|
103758-98-1
|
|
|
Fatty acids, tall-oil, polymers with Me epoxyoctadecanoate and tetraethylenepentamine
|
103759-08-6
|
|
|
2-[2-Amino(methyl)anilino]-1-ethanol
|
103763-87-7
|
C9H14N2O
|
|
(R)-2-(2-OXO-PYRROLIDIN-1-YL)-BUTYRAMIDE
|
103765-01-1
|
C8H14N2O2
|
|
(R)-(-)-2-AMINOBUTANAMIDE HYDROCHLORIDE, 97%
|
103765-03-3
|
C4H11ClN2O
|
|
5-AMINO-3-METHYL-THIOPHENE-2,4-DICARBOXYLIC ACID DIMETHYL ESTER
|
103765-33-9
|
C9H11NO4S
|
|
21β-[2-O-(β-D-Glucopyranosyl)-β-D-glucopyranosyloxy]-3β,23-dihydroxyolean-12-en-28-oic acid
|
103766-07-0
|
C42H68O15
|
|
4H-Cyclopentoxazole-4,5-diol, 2-(dimethylamino)-3a,5,6,6a-tetrahydro-6-(hydroxymethyl)-, (3aR,4R,5R,6R,6aS)-
|
103766-13-8
|
C9H16N2O4
|
|
Gimeracil
|
103766-25-2
|
C5H4ClNO2
|
|
BOF A1
|
103767-48-2
|
C37H27FN4O10
|
|
3-(2-HYDROXYETHYL)THIAZOLIUM BROMIDE
|
103768-99-6
|
C5H8BrNOS
|
|
oxazolopyridocarbazole
|
103769-63-7
|
C16H9N3O
|
|
2,5-Pyridinediamine,N,N-dinitro-(9CI)
|
103769-72-8
|
C5H5N5O4
|
|
2(1H)-Pyridinimine,N-nitro-(9CI)
|
103769-75-1
|
C5H5N3O2
|
|
3-Pyridinamine,1,6-dihydro-N-nitro-6-(nitroimino)-(9CI)
|
103769-76-2
|
C5H5N5O4
|
|
N-(8-aminohexyl)-5-iodonaphthalene-1-sulfonamide
|
103771-11-5
|
C16H21IN2O2S
|
|
N-(8-aminooctyl)-5-iodonaphthalene-1-sulfonamide
|
103771-14-8
|
|
|
1-Pyrrolidinecarboxamide,2-methoxy-(9CI)
|
103772-04-9
|
C6H12N2O2
|
|
5-NITRO-2,3,4,5-TETRAFLUORO BENZOYL CHLORIDE
|
103772-10-7
|
C7ClF4NO3
|
|
1-CYCLOPROPYL-5-NITRO-6,7,8-TRIFLUORO-1,4-DIHYDRO-4-OXO-3- QUINOLINECARBOXYLIC ACID ETHYL ESTER
|
103772-12-9
|
C15H11F3N2O5
|
|
1-CYCLOPROPYL-5-AMIDO-6,7,8-TRIFLUORO-1,4-DIHYDRO-4-OXO-3- QUINOLINECARBOXYLIC ACID ETHYL ESTER
|
103772-13-0
|
C15H13F3N2O3
|
|
5-Amino-l-Cyclopropyl-6,7, 8-Trifluoro-1,4-Dihydro-4-Oxo-3-Quinolinearboxylic Acid
|
103772-14-1
|
C13H9F3N2O3
|
|
H-D-HIS(BZL)-OH
|
103772-40-3
|
C13H15N3O2
|
|
2-Propenal, 3-(2,2-dimethyl-1,3-dioxolan-4-yl)-, (2E)-
|
103773-42-8
|
C8H12O3
|
|
GANODERIC ACID C2
|
103773-62-2
|
C30H46O7
|
|
1,5-DIMETHYL-4-PHENYLTETRAHYDRO-2H-IMIDAZOL-2-ONE
|
103774-40-9
|
C11H14N2O
|
|
Quinapril hydrochloride EP impurity G
|
103775-06-0
|
C25H31ClN2O5
|
|
Moexipril
|
103775-10-6
|
C27H34N2O7
|
|
[3S-[2[R*(S*)]],3S*]-2-[2-[[l- (Ethoxycarbonyl)-3-phenylpropyl] aMino]-l-oxopropyl]-1,2,3,4-tetrahydro-6,7-diMethoxy-3-isoquinolinecarboxylic Acid
|
103775-11-7
|
C27H34N2O7
|
|
MOEXIPRILAT HYDRATE
|
103775-14-0
|
C25H30N2O7
|
|
(R)-(-)-2-HYDROXYPROPYL P-TOLUENESULFONATE
|
103775-61-7
|
C10H14O4S
|
|
Miboplatin
|
103775-75-3
|
C6H14N2.C3H4O3Pt
|
|
2-Azetidinone,4-(1-methylethyl)-1-propyl-(9CI)
|
103776-28-9
|
C9H17NO
|
|
Methyl, hydroxy(4-nitrophenyl)- (9CI)
|
103776-53-0
|
C7H6NO3
|
|
2-Propenoic acid, 2-(dimethylamino)ethyl ester, polymer with 2-propenamide, sulfate
|
103777-67-9
|
C10H20N2O7S
|
|
STEARETH-100/PEG-136/HDI COPOLYMER
|
103777-69-1
|
|
|
(-)-4a,5a,9a,9b-Tetrahydro-1,4,4a,6,8-pentahydroxy-4,5a,7,9b-tetramethyl-2,9-bis(1-oxo-2,4-hexadienyl)dibenzofuran-3(4H)-one
|
103779-43-7
|
|
|
NOT I
|
103780-20-7
|
|
|
RESTRICTION ENDONUCLEASE SNAB I FROM*SPH AEROTILUS N
|
103780-21-8
|
|
|
METHYL 6-BENZYLOXYINDOLE-2-CARBOXYLATE
|
103781-89-1
|
C17H15NO3
|
|
4-(DiMethoxyMethyl)benzaldehyde
|
103781-93-7
|
C10H12O3
|
|
(7R)-10α-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-ethyl-7,8,9,10-tetrahydro-1,6,7β,8α,11-pentahydroxy-5,12-naphthacenedione
|
103782-06-5
|
|
|
ALLOSAMIDIN
|
103782-08-7
|
C25H42N4O14
|
|
1,1,1-Tris(hydroxyMethyl)propane-d4
|
103782-76-9
|
C6H14O3
|
|
1-(2-bromoethyl)-1,3-dihydro-2H-Benzimidazol-2-one
|
103784-03-8
|
C9H9BrN2O
|
|
1-(3-BroMopropyl)-1,3-dihydro-2H-benziMidazol-2-one
|
103784-04-9
|
C10H11BrN2O
|
|
4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]BENZALDEHYDE
|
103788-59-6
|
C19H17NO3
|
|
2,4-Thiazolidinedione, 5-[(4-hydroxyphenyl)methylene]-
|
103788-60-9
|
C10H7NO3S
|
|
4-(CHLOROMETHYL)-5-METHYL-2-PHENYL-1,3-OXAZOLE
|
103788-61-0
|
C11H10ClNO
|
|
2-broMo-1-(5-Methyl-2-phenyloxazol-4-yl)ethanone
|
103788-62-1
|
C12H10BrNO2
|
|
METHYL 2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ACETATE
|
103788-64-3
|
C13H13NO3
|
|
2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethan-1-ol
|
103788-65-4
|
C12H13NO2
|
|
METHYL 3-(4-NITROPHENOXY)-2-THIOPHENECARBOXYLATE
|
103790-37-0
|
C12H9NO5S
|
|
METHYL 3-(4-AMINOPHENOXY)-2-THIOPHENECARBOXYLATE
|
103790-38-1
|
C12H11NO3S
|
|
TERT-BUTYL 3-(4-AMINOPHENYL)PROPANOATE
|
103790-48-3
|
C13H19NO2
|
|
Benzeneacetaldehyde, 4-formyl- (9CI)
|
103790-65-4
|
C9H8O2
|
|
(1R)-7-Methoxy-1,2,3,4-tetrahydronaphthalen-1-aMine
|
103791-15-7
|
C11H15NO
|
|
(1S)-7-Methoxy-1,2,3,4-tetrahydronaphthalen-1-aMine
|
103791-17-9
|
C11H15NO
|
|
1H-Inden-1-ol, 1-(aminomethyl)-2,3-dihydro-
|
103791-35-1
|
C10H13NO
|
|
2(1H)-Pyridinone,3-chloro-6-hydroxy-(9CI)
|
103792-71-8
|
C5H4ClNO2
|
|
2(1H)-Pyridinone,3-chloro-4-hydroxy-(9CI)
|
103792-81-0
|
C5H4ClNO2
|
|
2(1H)-Pyridinone,3-amino-4-hydroxy-(9CI)
|
103792-82-1
|
C5H6N2O2
|
|
proglycosyn
|
103793-22-2
|
C13H17BrN2O2
|
|
2-Azabicyclo[2.1.1]hexane-1-carboxamide,2-acetyl-N-methyl-(9CI)
|
103794-02-1
|
C9H14N2O2
|
|
2-Azabicyclo[2.1.1]hexane-1-carboxamide,N-methyl-(9CI)
|
103794-07-6
|
C7H12N2O
|
|
N-(4-(4-maleimidophenyl)butyryl)phosphatidylethanolamine
|
103794-17-8
|
C47H77N2O11P
|
|
(2,2-DIMETHYL-[1,3]DIOXOLAN-4-YL)-HYDROXY-ACETIC ACID ETHYL ESTER
|
103795-12-6
|
C14H18O4
|
|
Hydrocortisone IMpurity I
|
103795-84-2
|
C21H30O6
|
|
4,5-DIETHOXY-2-NITRO BENZOIC ACID
|
103796-34-5
|
C11H13NO6
|
|
Indoline, 6-amino-2-methyl- (6CI)
|
103796-39-0
|
C9H12N2
|
|
Quinazoline, 5,6,7,8-tetrahydro-4-methyl- (6CI)
|
103796-40-3
|
C9H12N2
|
|
6''-AMINO-1,2,3,4-TETRAHYDROQUINOLINE
|
103796-41-4
|
C9H12N2
|
|
4-AMINO-3,5-DIMETHYL-BENZAMIDE
|
103796-44-7
|
C9H12N2O
|
|
4-ETHOXY-3-METHOXYPHENYLACETONITRILE
|
103796-52-7
|
C11H13NO2
|
|
1-Naphthoicacid,2-amino-1,2,3,4-tetrahydro-(6CI)
|
103796-56-1
|
C11H13NO2
|
|
1-Naphthalenecarboxylicacid,6-amino-1,2,3,4-tetrahydro-(9CI)
|
103796-57-2
|
C11H13NO2
|
|
1-METHYLINDOLIN-6-AMINE
|
103796-62-9
|
C9H12N2
|
|
3-ETHOXY-4-METHOXYPHENYLACETONITRILE
|
103796-99-2
|
C11H13NO2
|
|
4-TERT-BUTYL-2-NITRO-BENZOIC ACID
|
103797-19-9
|
C11H13NO4
|
|
Butyric acid, 2-benzamido-2-hydroxy- (6CI)
|
103797-20-2
|
C11H13NO4
|
|
methyl 2-methyl-2-(3-nitrophenyl)propanoate
|
103797-22-4
|
C11H13NO4
|
|
6-ETHYL-4-HYDROXY-QUINOLINE-3-CARBOXYLIC ACID
|
103802-41-1
|
C12H11NO3
|
|
2H-1-Benzopyran-2-one
|
103802-83-1
|
C14H23O5PS
|
|
[1,1'-(4a,5a,6,7,9a,9b-Hexahydro-2,4,5a,6,9-pentahydroxy-3,4a,6,9a-tetramethyl-1,8-dibenzofurandiyl)bis(2,4-hexadien-1-one)]
|
103804-06-4
|
C28H34O8
|
|
1-[9-(1-Oxo-4-hexenyl)-3,4,4a,5a,9a,9b-hexahydro-1,4,4a,6,8-pentahydroxy-4,5a,7,9b-tetramethyldibenzofuran-2-yl]-2,4-hexadien-1-one
|
103804-08-6
|
|
|
2',3'-Dihydro-[1,1'-(4a,5a,6,7,9a,9b-hexahydro-2,4,5a,6,9-pentahydroxy-3,4a,6,9a-tetramethyl-1,8-dibenzofurandiyl)bis(2,4-hexadien-1-one)]
|
103804-09-7
|
C28H36O8
|
|
3,3-dimethyl-4-hydroxy butyronitrile
|
103804-80-4
|
C6H11NO
|
|
8-(2,3-Dihydroxy-3-methylbutyl)-7-(β-D-glucopyranosyloxy)-2H-1-benzopyran-2-one
|
103805-93-2
|
C20H26O10
|